Cognitive Effects of 500mg Trans-resveratrol

Northumbria University logo

Northumbria University

Status

Completed

Conditions

Mood
Cognitive Performance

Treatments

Other: Placebo
Dietary Supplement: Trans-resveratrol

Study type

Interventional

Funder types

Other

Identifiers

NCT01794351
22P5

Details and patient eligibility

About

This study investigated the potentially cognitive enhancing effects of 500mg trans-resveratrol in healthy, young humans.

Enrollment

50 patients

Sex

All

Ages

18 to 35 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • 18-35yrs, healthy.

Exclusion criteria

  • Drug/alcohol abuse, taking prescription medication (apart from contraception) or herbal supplements, having food intolerances or allergies, having suffered a head-injury or neurological/neuro-developmental disorder, uncorrected sight problems, pregnant or seeking to become so, excessive caffeine use (e.g. more than 6 cups of coffee per day).

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Triple Blind

50 participants in 2 patient groups

Placebo then resveratrol
Experimental group
Description:
Participants in this arm (decided according to Latin square) first received placebo and then resveratrol, on seperate days, with a 7-14 day wash-out period between visits.
Treatment:
Dietary Supplement: Trans-resveratrol
Other: Placebo
Resveratrol then placebo
Experimental group
Description:
Participants in this arm (decided according to Latin square) first received resveratrol and then placebo, on seperate days, with a 7-14 day wash-out period between visits
Treatment:
Dietary Supplement: Trans-resveratrol
Other: Placebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems